WAM
IMGN

Wolverine Asset Management’s Immunogen Inc IMGN Stock Holding History

Wolverine Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-13,100
Closed -$60K – 1833
2020
Q2 		$60K Hold
13,100
– – ﹤0.01% 1201
2020
Q1 		$44K Hold
13,100
– – ﹤0.01% 1190
2019
Q4 		$66K Buy
+13,100
New +$44.5K ﹤0.01% 1157
2017
Q4 		– Sell
-2,500
Closed -$19K – 1647
2017
Q3 		$19K Hold
2,500
– – ﹤0.01% 1250
2017
Q2 		$17K Buy
+2,500
New +$11.4K ﹤0.01% 1196
2016
Q4 		– Sell
-45,600
Closed -$122K – 1359
2016
Q3 		$122K Buy
45,600
+30,500
+202% +$88.7K ﹤0.01% 945
2016
Q2 		$46K Buy
+15,100
New +$94.7K ﹤0.01% 1045

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wolverine Asset Management's IMGN Position: Q1 2024 in Review

Wolverine Asset Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 93,223 shares — an estimated $2.76M sold.

Wolverine Asset Management first reported a position in IMGN in Q2 2015 and held it in 3 quarters. The position peaked at $2.76M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Wolverine Asset Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Wolverine Asset Management sold 93,223 Immunogen Inc shares in Q1 2024, an estimated $2.76M.
  • Wolverine Asset Management first reported a position in Immunogen Inc in Q2 2015 and held it in 3 quarters.
  • Wolverine Asset Management's Immunogen Inc position peaked at $2.76M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Wolverine Asset Management's 13F filing for Q1 2024, filed 13 May 2024.